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Abstract 
The endothelial-specific receptor, tyrosine kinase with immunoglobulin-like loops and 
epidermal growth factor homology domains-2 (Tie2) is a member of the tyrosine kinase 
family and is ubiquitous in normal tissues; however, little is known about the mechanisms 
and roles of Tie2 in oral squamous cell carcinomas (OSCCs). In the current study, we 
investigated the expression status of Tie2 in OSCCs by quantitative reverse transcriptase-
polymerase chain reaction, immunoblotting, and immunohistochemistry and the functional 
mechanisms of Tie2 using its overexpressed OSCC (oeTie2) cells and Tie2 blocking by its 
antibody. We found that Tie2 expression was down-regulated significantly (p < 0.05) in 
OSCCs compared with normal counterparts in vitro and in vivo. Interestingly, oeTie2 cells 
showed higher cellular adhesion (p < 0.05) and lower cellular invasion (p < 0.05) compared 
with control cells; whereas there was similar cellular proliferation in both transfectants. 
Furthermore, cellular adhesion was inhibited and invasion was activated by Tie2 function-
blocking antibody (p < 0.05), indicating that Tie2 directly regulates cellular adhesion and 
invasion. As expected, among the clinical variables analyzed, Tie2-positivity in patients 
with OSCC was correlated closely with negative lymph node metastasis. These results 
suggested for the first time that Tie2 plays an important role in tumor metastasis and may 
be a potential therapeutic target for OSCC metastasis. 
  
  
Introduction 
Tyrosine kinase with immunoglobulin-like loops and epidermal growth factor homology 
(Tie) domains, i.e., Tie1 and Tie2, is a member of the endothelial-specific receptor tyrosine 
kinase (RTK) [1, 2], which is essential for formation of embryonic vasculature [3]. Tie2 
maintains the vascular integrity of mature vessels by enhancing endothelial barrier function 
[4-8]. Gene-targeting analyses of Tie2 have identified the necessity for these vascular 
endothelial RTKs for neovascular formation in ischemic diseases and tumors [9]. However, 
Tie1 is expressed exclusively in endothelial cells, but its role is incompletely defined.  
Tie2 is tyrosine phosphorylated in normal adult endothelium tissues and expressed 
in the endothelium of neovessels of regenerating organs and several types of tumor, 
including leukemia, breast, gastric, and thyroid cancers [10-15]. There is, however, little 
information about Tie2 function in oral squamous cell carcinomas (OSCCs). 
The current study found for the first time that Tie2 expression is correlated closely 
with regional lymph node metastasis in OSCCs. Processes involved in tumor metastasis 
include loss of cell-cell and/or cell-extracellular matrix (ECM) adhesion, which allows 
these cells to migrate from their site of origin, degrade the ECM, acquire motility, and 
invade phenotypes leading to metastases [16-18]. We found that Tie2 expression was 
significantly lower in OSCCs than in normal counterparts in vitro and in vivo and that a 
model of Tie2 overexpression showed novel Tie2 functions in OSCCs. Our results 
indicated that Tie2 may be a potential therapeutic target for patients with OSCC. 
  
  
Materials and Methods 
Ethics statement 
The Ethics Committee of the Graduate School of Medicine, Chiba University approved the 
study protocol (approval number, 236), which was performed according to the tenets of the 
Declaration of Helsinki. All patients provided written informed consent. 
 
OSCC-derived cell lines and tissue specimens  
OSCC-derived cell lines (HSC-2, HSC-3, HSC-4, KOSC-2, Sa3, Ca9-22, SAS, HO-1-N-
1, and HO-1-u-1) were obtained from the Human Science Research Resources Bank 
(Osaka, Japan) or the RIKEN BioResource Center (Tsukuba, Japan) through the National 
Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and 
Technology. Short tandem repeat profiles confirmed cellular identity. As described in 
detail previously [19-25], primary cultured human normal oral keratinocytes (HNOKs) 
were obtained from healthy oral mucosa epithelium specimens collected from young 
patients at Chiba University Hospital. Three independent HNOKs were primary cultured 
and maintained in oral keratinocyte medium (ScienCell Research Laboratories, Carlsbad, 
CA, USA) comprised of 5 ml of oral keratinocyte growth supplement (ScienCell Research 
Laboratories) and 5 ml of penicillin/streptomycin solution (ScienCell Research 
Laboratories) [19-25]. OSCC cells were grown in Dulbecco’s modified Eagle medium 
(DMEM) (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% FBS (Sigma-
Aldrich) and 50 units/ml of penicillin and streptomycin (Sigma-Aldrich). Seventy pairs of 
primary OSCCs and patient-matched normal oral epithelia were obtained during surgical 
resections performed at Chiba University Hospital after the patients provided informed 
  
consent. The resected tissues were divided into two parts, one of which was frozen 
immediately and stored at -80°C until RNA isolation, and the second of which was fixed 
in 20% buffered formaldehyde solution for pathologic diagnosis and 
immunohistochemistry (IHC). Histopathologic diagnosis of each tissue was performed 
according to the World Health Organization criteria at the Department of Pathology of 
Chiba University Hospital. Clinicopathological staging was determined based on the 
tumor-node-metastasis classification of the International Union against Cancer. All 
patients had histologically confirmed OSCC, and the tumor samples were evaluated to 
ensure that tumoral tissue was present in more than 80% of the specimen. 
 
mRNA expression analysis 
Total RNA was isolated using Trizol Reagent (Invitrogen, Carlsbad, CA, USA), according 
to the manufacturer’s instructions. cDNA was generated from 5 μg of total RNA using 
Ready-To-Go You-Prime First-Strand Beads (GE Healthcare, Buckinghamshire, UK) and 
oligo (dT) primer (Hokkaido System Science, Sapporo, Japan) according to the 
manufacturers’ instructions. As described in detail previously [22], real-time quantitative 
reverse transcriptase-polymerase chain reaction (qRT-PCR) was performed using the 
LightCycler 480 apparatus (Roche Diagnostics, Mannheim, Germany). Primers were 
designed using the Universal ProbeLibrary Assay Design Center 
(http://lifescience.roche.com/), which specifies the most suitable set. The primer sequences 
used for qRT-PCR were: Tie2, forward, 5′-CCC CTA TGG GTG TTC CTG T-3′; reverse, 
5′-GCT TAC AAT CTG GCC CGT AA-3′; and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), forward, 5′-AAC ATC ATC CCT GCC TCT ACT GG-3′; 
  
reverse, 5′-TTG AAG TCA GAG GAG ACC ACT G-3′. The transcript amount was 
estimated from the respective standard curves and normalized to the GAPDH transcript 
amount determined in corresponding samples. All samples were analyzed in triplicate, and 
three independent preparations of RNA were analyzed from each cell line. 
 
Immunoblot analysis 
The cells were washed twice with cold phosphate-buffered saline (PBS) and centrifuged 
briefly. The cellular pellets were incubated at 4°C for 30 minutes in a lysis buffer (7 M 
urea, 2 M thiourea, 4% (w/v) CHAPS, and 10 mM Tris) with a proteinase inhibitor cocktail 
(Roche Diagnostics). The protein concentration was measured using a commercial 
Bradford reagent (Bio-Rad, Richmond, CA, USA). Immunoblot analysis was performed 
described previously [22-25]. Briefly, protein extracts (20 μg) were electrophoresed on 4-
12% Bis-Tris gel (Invitrogen), transferred to polyvinylidene fluoride membranes 
(Invitrogen), and blocked for 1 hour at room temperature in Blocking One (Nacalai Tesque, 
Kyoto, Japan). The membranes were washed three times with 0.1% Tween-20 in Tris-
buffered saline (TBS-T) and incubated with affinity-purified rabbit anti-Tie2 polyclonal 
antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or mouse anti-GAPDH 
monoclonal antibody (Santa Cruz Biotechnology) overnight at 4°C. The membranes were 
washed with TBS-T and incubated with horseradish peroxidase-conjugated anti-rabbit or 
anti-mouse IgG as a secondary antibody (Promega, Madison, WI, USA) for 1 hour at room 
temperature. Finally, the membranes were detected using Super-Signal West Pico 
Chemiluminescent substrate (Thermo Fisher Scientific, Rockford, IL, USA), and 
immunoblot analyses were visualized by exposing the membranes to BioRad ChemiDoc 
  
XRS system (BioRad).The signal intensities were quantitated using Image Lab software 
(BioRad). Densitometric Tie2 protein data were normalized to GAPDH protein levels. 
 
IHC 
IHC was performed on 4-μm sections of paraffin-embedded specimens using rabbit anti-
Tie2 polyclonal antibody (Santa Cruz Biotechnology). Briefly, after deparaffinization and 
hydration, the endogenous peroxidase activity was quenched by a 3-minute incubation in 
a mixture of 0.3% hydrogen peroxide solution in 100% methanol. The sections were 
blocked for 2 hours at room temperature with 1.5% blocking serum (Santa Cruz 
Biotechnology) in PBS before reacting with the anti-Tie2 antibody at 4°C in a moist 
chamber overnight. Upon incubation with the primary antibody, the specimens were 
washed three times in PBS and treated with Envision reagent (DAKO, Carpinteria, CA, 
USA) followed by color development in 3,3’-diaminobenzidine tetrahydrochloride 
(DAKO). The slides then were lightly counterstained with hematoxylin, dehydrated with 
ethanol, cleaned with xylene, and mounted. Nonspecific binding of the antibodies to other 
proteins sometimes occurred. As a negative control, triplicate sections were 
immunostained without exposure to primary antibodies, which confirmed the staining 
specificity. To quantify the status of Tie2 protein expression in those components, we used 
the IHC scoring systems described previously [22, 26-29]. The mean percentages of 
positively stained cells were determined in at least three random fields at 400× 
magnification in each section. The intensity of the Tie2 immunoreaction was scored as 
follows: 0+, none; 1+, weak; 2+, moderate; and 3+, intense. The cellular numbers and the 
staining intensities were multiplied to produce Tie2 IHC scores. To determine the cutoff 
  
points of Tie2 IHC scores, we analyzed the IHC scores of 70 patients using the receiver 
operating characteristic curve (ROC) and Youden index. Cases with a score over 72.5 
(ROC curve and Youden index for normal tissue) were considered Tie2-negative. Two 
independent pathologists from Chiba University Hospital, neither of whom had knowledge 
of the patients’ clinical status, made these judgments. 
 
Transfection of Tie2 overexpression vector 
OSCC-derived cells (SAS and Sa3) were transfected with Tie2 vector designed to cause 
overexpression of Tie2 cDNA (oeTie2 cells) (OriGene Technologies, Rockville, MD, 
USA) and non-targeting vector (Mock cells) (OriGene Technologies) using Lipofectamine 
3000 (Invitrogen). After transfection, the cells that stably overexpressed Tie2 were isolated 
by the selection marker, G-418 Solution (Roche Diagnostics). Two to three weeks after 
incubation with G-418 Solution, individual clones were isolated and used for further 
experiments.  
 
Proliferation assay  
To investigate the effect of Tie2 overexpression on cellular proliferation, oeTie2 and Mock 
cells were seeded in six-well plates at a density of 1 × 104 viable cells/well. At the indicated 
time points, the cells were trypsinized and counted in triplicate using a hemocytometer[22-
25]. 
 
Adhesion assay  
Collagen I-coated 96-well plates were incubated for 1 hour at 37°C. Adhesion assay was 
  
preformed described previously [23]. Briefly, the cells were seeded at a density of 2 ×104 
cells/well and incubated for 1 hour in DMEM, washed once with PBS, fixed in methanol, 
stained with crystal violet, and photographed. The numbers of stained cells were measured 
using a microplate spectrophotometer (absorbance at 540 nm and at 405 nm to subtract the 
background). 
 
Invasion assay  
Invasion assay was preformed described previously [23]. Briefly, a total of 2.5 ×105 cells 
resuspended in serum-free medium were seeded on a polyethylene terephthalate membrane 
insert with a pore size of 8 μm in a trans-well apparatus (Becton Dickinson, Franklin Lakes, 
NJ, USA). Two milliliters of DMEM with 10% FBS was added to the lower chamber. After 
the cells were incubated for 72 hours at 37°C, the insert was washed with PBS, and cells 
on the top surface of the insert were removed with a cotton swab. Cells adhering to the 
lower surface of the membrane were stained with crystal violet/methanol, and the number 
of cells entering the pores in five random fields was counted using a light microscope at 
100×magnification. 
 
Inhibition of cellular adhesion and invasion by blocking Tie2 
The Tie2 overexpressed cells and control cells were resuspended in serum-free medium. 
The cellular suspension was incubated with the indicated concentrations of Tie2 polyclonal 
antibody (Santa Cruz Biotechnology) for 30 minutes at room temperature. The cells were 
seeded and cellular adhesion and invasion assays were performed. 
 
  
Statistical analysis  
To compare Tie2 expression levels, statistical significance was evaluated using the Mann-
Whitney U-test. The relationships between the Tie2 IHC scores and clinicopathological 
profiles were evaluated using the χ2 test, Fisher’s exact test, and Mann-Whitney U-test. P 
< 0.05 was considered significant. The data are expressed as the mean ± standard error of 
the mean. 
  
  
Results  
1. Down-regulation of Tie2 in OSCC-derived cell lines  
To investigate the expression status of Tie2, identified as a cancer-related gene by our 
previous microarray data [30], we performed qRT-PCR and immunoblot analyses using 
nine OSCC-derived cell lines (HSC-2, HSC-3, HSC-4, KOSC-2, Sa3, Ca9-22, SAS, HO-
1-N-1, and HO-1-u-1) and HNOKs. Tie2 mRNA was down-regulated significantly (p < 
0.05) in all OSCC-derived cell lines compared with the HNOKs (Fig. 1A). Fig. 1B shows 
representative results of immunoblot analysis. The Tie2 protein expression decreased 
significantly (p < 0.05) in all OSCC-derived cell lines compared with the HNOKs.  
 
2. Evaluation of Tie2 expression in primary OSCCs  
We analyzed the Tie2 protein expression in primary OSCCs using the IHC scoring system 
[19, 22, 26-29, 31, 32]. The Tie2 IHC scores in normal oral tissues and OSCCs ranged 
from 65.0 to 125.0 (median, 95.0) and 20.0 to 90.0 (median, 58.75), respectively. The IHC 
scores in primary OSCCs were significantly (p < 0.05) lower than in normal oral tissues 
(Fig. 2A). Representative IHC results for Tie2 protein in normal oral tissue and primary 
OSCC are shown in Fig. 2B and C, respectively. Strong Tie2 immunoreactivity was 
detected in normal tissue, whereas the OSCC tissue showed almost negative 
immunostaining (Fig. 2C). To determine an optimal cutoff point of the identified IHC 
scores, we used the ROC curve analysis and Youden index. ROC curve analysis (area 
under the curve, 0.95132; 95% confidence interval, 0.9219-0.9807; p < 0.05) and Youden 
index (sensitivity, 78.6%; specificity, 95.7%, p < 0.05) showed that the cutoff value was 
72.5. (Fig. 2D, E). 
  
 
3. Establishment of Tie2 overexpressed cells  
Since frequent down-regulation of Tie2 was observed in OSCC in vitro and in vivo (Figs. 
1 and 2), the OSCC-derived cells (SAS and Sa3) were transfected with oeTie2 and non-
targeting vector (Mock) to investigate the Tie2 function in OSCC cells. To assess the 
efficiency of the transfection, we performed qRT-PCR and immunoblot analyses. The Tie2 
mRNA expression in the oeTie2 cells was significantly (p < 0.05) higher than in Mock 
cells (Fig. 3A). The Tie2 protein level in the oeTie2 cells also increased compared with 
Mock cells (Fig. 3B). 
 
4. Functional analyses of Tie2 overexpressed cells  
We performed a cellular proliferation assay to evaluate the effect of Tie2 overexpression 
on cellular growth. The Mock and oeTie2 cells had similar growth curves, indicating that 
overexpression of Tie2 did not affect cellular growth (Fig. 4). We then carried out cellular 
adhesion and invasion assays to determine the biologic effects of Tie2 in SAS and Sa3 cells 
(Figs. 5, 6, respectively).  
Cellular adhesion in the oeTie2 cells significantly increased (p < 0.05) compared with 
the Mock cells (Fig. 5A). We further examined whether the adhesion activity of Tie2 
overexpressed cells varied when Tie2 was blocked. The adhesion activity of oeTie2 cells 
treated with Tie2 polyclonal antibody was inhibited dramatically in a dose-dependent 
manner (Fig. 5B, C). In addition. oeTie2 cells showed decreased cellular invasion  
compared with Mock cells (Fig. 6A; p < 0.05). After treatment with Tie2 polyclonal 
antibody, invasion of oeTie2 cells was activated significantly compared with the untreated 
  
cells (Fig. 6B), suggesting that Tie2 may directly regulate cellular adhesion and invasion.  
 
5. Correlation between Tie2 expression and clinical 
classifications of OSCCs  
The correlations between the clinicopathologic characteristics of patients with OSCC and 
their Tie2 protein levels using the IHC scoring system are shown in Table 1. Among the 
clinical classifications, Tie2-negative patients exhibited significantly (p < 0.01) more 
regional lymph node metastasis compared with Tie2-positive patients. 
  
  
Discussion 
Tie2 was down-regulated in OSCC in vitro and in vivo and that Tie2 controls cellular 
adhesion and invasion activities. As expected, no metastases to regional lymph nodes 
occurred in patients with OSCC who were Tie2-positive (Table 1, p < 0.05). 
Although Tie2 first was identified as an endothelial cell-specific receptor for 
vascular remodeling and stabilization signals in angiogenesis [3, 16, 33-38], research has 
shown the presence of RTK in the non-stromal cell population of cancers [17, 18, 38] such 
as leukemia and gastric, thyroid, and breast cancers [15, 39-41]. Tie2 was overexpressed 
in gastric, breast, and hepatocellular cancers and related to tumor angiogenesis [42, 43]. In 
contrast, the current results showed that Tie2 was down-regulated in OSCCs; therefore, 
Tie2 plays pivotal roles in tumor metastasis of several types of cancers. 
In the current study, we explored the anti-metastasis activities of Tie2 in OSCC, 
because Tie2 expression in OSCC was correlated significantly with lymph node metastasis 
using our IHC scoring system (Table 1). Cancer metastasis requires loss of cell-cell and 
cell-ECM adhesions and invasion through the ECM. Cellular adhesion is maintained in 
epithelial tissues by the adherens junction, which is down-regulated in many cancers to 
promote transformation and may profoundly affect cellular motility and differentiation [44-
48]. ECM degradation decreases cellular adhesion and increases cellular invasion [49], 
indicating that the ECM functions are not limited to a structural role but may affect multiple 
and diverse functions of cancer cells. 
The cellular adhesion activity of Tie2 had been reported in human umbilical vein 
endothelial cells [50]. Consistent with that study, our functional analyses indicated that 
Tie2-overexpressed cells acquired self-sustained cellular adhesion and decreased invasion 
  
phenotypes, suggesting that Tie2 would be, in part, a key modulator of OSCC tumor 
adhesion and invasion. Although the biologic meaning of these molecular interactions 
remains to be determined, Tie2 seems to have complex regulatory mechanisms, especially 
in oral cancer metastasis. In addition to a previous study in which patients with 
angiosarcoma with high expression of Tie2 had a good prognosis [51], no metastases 
occurred in patients with Tie2-positive OSCC. 
We speculated that Tie2 expression levels are correlated closely with vascular 
invasion, because our data indicated that Tie2 controls cellular adhesion and invasion. 
Consistent with that hypothesis, patients with OSCC who were Tie2-positive tended to 
have high vascular invasion. However, there was no significant difference between Tie2-
positivity and Tie2-negativity (Table 1, p < 0.203).  
In conclusion, using several approaches, we showed that Tie2 is expressed not only 
in the human vascular system but also in human normal oral tissue and OSCC. These 
results, together with the fact that OSCCs express low levels of Tie2, suggested that a 
previously unknown Tie2 function in OSCC cells controls critical aspects of the metastatic 
behavior of OSCCs. This provides new insight into the highly metastatic phenotype of 
OSCC. While further studies are needed to study Tie2, the current data suggested that Tie2 
plays an important role in cellular adhesion and invasion and may be a potential therapeutic 
target for OSCCs. 
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Legends 
Fig 1. Down-regulation of Tie2 expression in OSCC-derived cell lines. (A) 
Quantification of Tie2 mRNA expression in OSCC-derived cell lines by qRT-PCR analysis. 
Significant down-regulation of Tie2 mRNA is seen in nine OSCC-derived cell lines 
compared with HNOKs (*p < 0.05, Mann-Whitney U-test). Data are expressed as the 
means ± standard errors of the mean of triplicate results. (B) Immunoblot analysis of Tie2 
protein in OSCC-derived cell lines and HNOKs. Tie2 protein expression is down-regulated 
in OSCC-derived cell lines compared with HNOKs. Densitometric Tie2 protein data are 
normalized to GAPDH protein levels. The values are expressed as a percentage of HNOKs. 
 
Fig 2. Evaluation of Tie2 expression in primary OSCCs. (A) The Tie2 IHC scores of 
normal oral tissues and OSCCs range from 65.0 to 125.0 (median, 95.0) and 20.0 to 90.0 
(median, 58.75), respectively. The IHC scores in primary OSCCs are significantly (*p < 
0.05, Mann-Whitney U-test) lower than in normal oral tissues. Representative IHC results 
for Tie2 protein in normal oral tissue (B) and primary OSCC (C). Strong Tie2 
immunoreactivity is seen in normal oral tissues, whereas the OSCCs show almost negative 
immunostaining. Original magnification, X 100. Scale bars, 100 μm. (D) The ROC curve 
analysis shows that the optimal cutoff point is 72.5 (area under the curve, 0.95132; 
95% confidence interval, 0.9219-0.9807; p < 0.05). (E) Youden Index analysis shows that 
the optimal cutoff point is 72.5 (sensitivity, 78.6%; specificity, 95.7%, p < 0.05).  
 
Fig 3. Establishment of Tie2 overexpressed cells. Significant (*p < 0.05, Mann-Whitney 
U-test) up-regulation of Tie2 mRNA (A) and protein (B) are observed in oeTie2 cells 
  
compared with Mock cells using qRT-PCR and immunoblot analyses. Densitometric Tie2 
protein data are normalized to GAPDH protein levels. The values are expressed as a 
percentage of the Mock cells.  
 
Fig 4. Cellular proliferation in Tie2 overexpressed cells. To determine the effect of Tie2 
overexpression on cellular proliferation, oeTie2 and Mock cells are seeded in six-well 
plates at a density of 1 × 104 viable cells/well. Both transfectants are counted on seven 
consecutive days. oeTie2 cells (SAS- and Sa3-derived transfectants; 2 clones each) do not 
affect cellular growth compared with Mock cells after 7 days (168 hours [hr]). The results 
are expressed as the means ± standard errors of the  mean of values from three assays.  
 
Fig 5. Adhesion assay of Tie2 overexpressed cells. (A) Adhesion assay of Tie2 
overexpressed cells. To evaluate the adhesion ability, oeTie2 and Mock cells are seeded on 
collagen I-coated 96-well plates at a density of 2 ×104 cells/well and allowed to adhere 
for 1 hour. After crystal violet staining, the numbers of stained cells are measured using a 
microplate spectrophotometer (absorbance at 540 nm and at 405 nm to subtract 
background). The cellular adhesion of the oeTie2 cells increased significantly (p < 0.05) 
compared with the Mock cells. (B, C) Inhibition of cellular adhesion by Tie2 antibody. 
oeTie2 cells are treated with Tie2 antibody before the adhesion assay. The numbers of 
oeTie2 cells attached to the dishes are decreased in a dose-dependent manner of the Tie2 
antibody (B, SAS cells; C, Sa3 cells). 
 
Fig 6. Invasion assay of Tie2 overexpressed cells. (A) Invasion assay of Tie2 
overexpressed cells. After crystal violet staining, the numbers of cells invading the pores 
  
are counted (×100 magnification). The numbers of penetrating oeTie2 cells are 
significantly lower than with Mock cells (*p < 0.05, Mann–Whitney U test). (B) Activation 
of cellular invasion by Tie2 antibody. The oeTie2 cells are treated with Tie2 antibody 
before the invasion assay. The numbers of oeTie2 cells invading the pores increase after 
treatment with Tie2 antibody (2 µg/ml) (B, SAS cells; C, Sa3 cells, ** p < 0.01). 
 
  
Table 1. Correlation between Tie2 expression and clinical classification in OSCCs. 
Clinical classification Total 
Immunostaining Results 
No. patients p valuea 
Tie2-negative Tie2-positive 
Age at surgery (years)     
  <60 18 14 4  
  ≧60, <70 20 13 7 0.788a 
  ≧70 32 25 7  
Gender     
  Male 47 34 13 
0.773b 
  Female 23 18 5 
T-primary tumor     
  T1 5 3 2 
0.051c 
  T2 48 33 15 
  T3 9 8 1 
  T4 8 8 0 
N-regional lymph node    
  Negative 53 35 18 
0.008b** 
  Positive 17 17 0 
Vascular invasion    
  Negative 53 37      16 
0.203c 
  Positive 17 15 2 
Stage     
  I 3 1 2 
0.006**c 
  II 49 28 21 
  III 19 15 4 
  IV 44 24 20 
Histopathologic type     
  Well 54 38 16 
0.175c   Moderately 13 11 2 
  Poorly 3 3 0 
Tumoral site     
  Tongue  47 35 12 
0.846c 
  Gingiva 14 9 5 
  Buccal mucosa 3 3 0 
  Soft palate 3 2 1 
  Oral floor 3 3 0 
**p < 0.01. 
aχ2 test. 
bFisher’s exact test. 
cMann-Whitney U-test. 
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